XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 14,100 $ 15,293
Accounts receivable, net of allowance for credit loss of $794 and $1,398, respectively 2,152 2,635
Prepaid expenses and other current assets 2,225 1,074
Total current assets 18,477 19,002
Property, equipment, and software, net 2,436 2,554
Restricted cash - long-term portion 248 251
Other assets 10 28
Total assets 21,171 21,835
Current liabilities    
Convertible promissory notes, net 29,221 0
Accounts payable 640 813
Accrued expenses and other current liabilities 3,608 2,503
Deferred revenue 1,877 1,764
Total current liabilities 35,346 5,080
Non-current liabilities    
Convertible promissory notes, net 0 29,085
Other long-term liabilities 96 128
Total non-current liabilities 96 29,213
Total liabilities 35,442 34,293
Commitments and contingencies (Note 10)
Stockholders' deficit    
Preferred stock: $0.0001 par value; 5,000,000 and 5,000,000 authorized; 0 and 0 issued and outstanding; aggregate liquidation preference of $0 and $0 at March 31, 2024 and December 31, 2023, respectively 0 0
Common stock: $0.0001 par value; 200,000,000 and 200,000,000 authorized; 2,455,556 and 2,392,568 issued at March 31, 2024 and December 31, 2023, respectively 0 0
Treasury stock: 154,055 and 154,055 shares held at March 31, 2024 and December 31, 2023, respectively (31,663) (31,663)
Additional paid-in capital 93,977 93,403
Accumulated deficit (76,585) (74,198)
Total stockholders' deficit (14,271) (12,458)
Total liabilities and stockholders' deficit $ 21,171 $ 21,835